AI identifies tumor aging patterns to predict immunotherapy response across multiple cancer types

Even when given the same drug, some patients respond well while others show little or no response. This is particularly true of immunotherapy. A research team at POSTECH (Pohang University of Science and Technology) has developed an artificial intelligence (AI) technology that can predict, in advance, which patients are likely to benefit from treatment.

Read it at Medical Xpress ↗

← Front page